Potassium superoxide | CAS:12030-88-5
Potassium superoxide
- 名称:过氧化钾; 超氧化钾 | Potassium superoxide
- CAS号:12030-88-5
- 别名:Potassium dioxide
- 分子式:KO2
- 分子量:71.09
- EINESC号:234-746-5
产品描述
物理化学性质
熔点 | 400 ºC |
---|---|
水溶性 | 起反应 |
安全数据
危险品标志 | O;C |
---|---|
危险类别码 | R14;R35;R8 |
安全说明书 | S17;S26;S36/37/39;S45;S8 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Electron tomography and 3D molecular simulations of platinum nanocrystals.Florea I Nanoscale, 4(16), 5125-5131 (2012)
Surface activity of water soluble amphiphilic chitin derivatives.Desbrieres J Polym. Bull., 39(2), 209-215 (1997)
Preparation of highly uniform Pickering emulsions by mercaptocarboxylated gold nanoparticles.Yamanaka K Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 436, 18-25 (2013)
Na(+)-H(+) exchanger inhibitor prevents early death in hereditary cardiomyopathy.Ghassan Bkaily et al.Canadian journal of physiology and pharmacology, 93(11), 923-934 (2015-08-21)
Cardioprotective efficacy against reperfusion injury of EMD-87580: Comparison to ischemic postconditioning.Juliana Fantinelli et al.European journal of pharmacology, 737, 125-132 (2014-05-27)
Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition.Sabzali Javadov et al.Basic research in cardiology, 106(1), 99-109 (2010-10-05)
Sodium-hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytes.Xiaohong Tracey Gan et al.Cardiovascular research, 85(1), 79-89 (2009-08-19)
Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4.Mohamed Mlih et al.Molecular and cellular biochemistry, 404(1-2), 211-220 (2015-03-12)
Phenylephrine and sustained acidosis activate the neonatal rat cardiomyocyte Na+/H+ exchanger through phosphorylation of amino acids Ser770 and Ser771.Ersilia Coccaro et al.American journal of physiology. Heart and circulatory physiology, 297(2), H846-H858 (2009-06-23)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!